iFLUX (Public limited company)
iFLUX is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0683.854.156. It was founded on 30-10-2017. Its registered office is in Niel. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -356 024 and a loss of € 1 311 060. These accounts report 11.4 full-time equivalents. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 14-10-2026.
Company information
Key figures of iFLUX
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -1 311 060+19 % | € -1 610 256-13 % | € -1 428 657-188 % | € -496 259 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -356 024 | € 955 036+27 % | € 752 005 | € -648 641 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 2 620 396-14 % | € 3 045 6870 % | € 3 052 021+62 % | € 1 887 956 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 449 843+400 % | € 90 020-21 % | € 114 391-73 % | € 419 841 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 11.4-3 % | 11.8-2 % | 12 | - |
Financial estimate
- 3 Shareholders
- 5 Board links
Similar companies
Other companies in the same activity in Niel.
| Company | Town |
|---|---|
| ETHERNA IMMUNOTHERAPIES | 2845 Niel |
| OXYPOINT | 2845 Niel |
| Clinical Projects International | 2845 Niel |
| anicells | 2845 Niel |
| GRAND MEDICAL (EUROPE) | 2845 Niel |
| SYNAPTIX | 2845 Niel |
| ImmuneSpec | 2845 Niel |
| EUROPEAN RESPIRATORY CLUSTER ANTWERP | 2845 Niel |
Frequently asked questions
Is iFLUX still active? Yes. The Crossroads Bank for Enterprises lists iFLUX as active.
What is the VAT number of iFLUX? The VAT number of iFLUX is BE 0683.854.156.
When was iFLUX founded? iFLUX was founded on 30-10-2017.
What is the address of iFLUX? The current registered office of iFLUX is Galileilaan 18, 2845 Niel.
When did iFLUX last file annual accounts? The latest annual accounts of iFLUX were filed on 01-07-2026.
Does iFLUX file its annual accounts on time? Yes. iFLUX filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does iFLUX have? iFLUX employs 11.4 full-time equivalents according to its most recent annual accounts.
Is iFLUX financially healthy? Addrly gives iFLUX a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is iFLUX profitable? The annual accounts of iFLUX for 2025 show a loss of € 1 311 060.
What is the equity of iFLUX? The equity of iFLUX was € -356 024 at the close of the 2025 financial year.
Who are the directors of iFLUX? The annual accounts of iFLUX record 9 mandates. The names, roles and dates are visible with a free account.
Can iFLUX receive Peppol e-invoices? Yes. iFLUX is registered on the Peppol network and can receive structured electronic invoices.
What does iFLUX do? The main activity of iFLUX is: Scientific research and development.